Zhejiang Qianjiang Biochemical Co., Ltd

SHSE:600796 Voorraadrapport

Marktkapitalisatie: CN¥4.3b

Zhejiang Qianjiang Biochemical Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Zhejiang Qianjiang Biochemical has a total shareholder equity of CN¥3.5B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 68.9%. Its total assets and total liabilities are CN¥7.5B and CN¥4.0B respectively. Zhejiang Qianjiang Biochemical's EBIT is CN¥244.9M making its interest coverage ratio 9.6. It has cash and short-term investments of CN¥910.2M.

Belangrijke informatie

68.9%

Verhouding schuld/eigen vermogen

CN¥2.42b

Schuld

Rente dekkingsratio9.6x
ContantCN¥910.21m
AandelenCN¥3.51b
Totaal verplichtingenCN¥3.98b
Totaal activaCN¥7.49b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Prospects Need A Boost To Lift Shares

Oct 01
Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Prospects Need A Boost To Lift Shares

Zhejiang Qianjiang Biochemical (SHSE:600796) Shareholders Will Want The ROCE Trajectory To Continue

May 13
Zhejiang Qianjiang Biochemical (SHSE:600796) Shareholders Will Want The ROCE Trajectory To Continue

There Is A Reason Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Price Is Undemanding

Feb 27
There Is A Reason Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Price Is Undemanding

Analyse van de financiële positie

Kortlopende schulden: 600796's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.8B).

Langlopende schulden: 600796's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥2.2B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 600796's net debt to equity ratio (43%) is considered high.

Schuld verminderen: 600796's debt to equity ratio has increased from 15% to 68.9% over the past 5 years.

Schuldendekking: 600796's debt is not well covered by operating cash flow (10.5%).

Rentedekking: 600796's interest payments on its debt are well covered by EBIT (9.6x coverage).


Balans


Ontdek gezonde bedrijven